Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 34, Issue 49, 2016, Pages 6027-6037

  Pathirana, Jayani ^a,b,c   Muñoz, Flor M ^d   Abbing Karahagopian, Victoria ^e   Bhat, Niranjan ^f   Harris, Tara ^g   Kapoor, Ambujam ^h   Keene, Daniel L ⁱ   Mangili, Alexandra ^j   Padula, Michael A ^k   Pande, Stephen L ^l   Pool, Vitali ^m   Pourmalek, Farshad ⁿ   Varricchio, Frederick ^o   Kochhar, Sonali ^p   Cutland, Clare L ^a,b,c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b NATIONAL RESEARCH FOUNDATION   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e Novartis Vaccine and Diagnostics   (Netherlands)

^f Program for Appropriate Technology in Health PATH   (United States)

^g PUBLIC HEALTH ONTARIO   (Canada)

^h PUBLIC HEALTH FOUNDATION OF INDIA   (India)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

^j TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^l Soroti Regional Referral Hospital   (Uganda)

^m SANOFI PASTEUR   (France)

ⁿ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^o Vaccinologist   (United States)

^p Healthcare Management Consultants   (India)

more..

Author keywords

Adverse event; Case definition; Guidelines; Maternal immunization; Neonatal death

Indexed keywords

ALGORITHM; APGAR SCORE; ARTICLE; DATA ANALYSIS; DRUG SAFETY; GESTATIONAL AGE; HUMAN; ICD-10; INFORMATION PROCESSING; LIVE BIRTH; MEDICAL INFORMATION; NEWBORN DEATH; NEWBORN PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VACCINATION; CHILD; CLINICAL TRIAL (TOPIC); FEMALE; IMMUNIZATION; INFANT; INFANT MORTALITY; MORBIDITY; MOTHER; NEWBORN; PERINATAL DEATH; PREGNANCY; STATISTICS;

VACCINE;

CHILD; CLINICAL TRIALS AS TOPIC; DATA COLLECTION; FEMALE; HUMANS; IMMUNIZATION; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MORBIDITY; MOTHERS; PERINATAL DEATH; PREGNANCY; STATISTICS AS TOPIC; VACCINES;

EID: 84978863588     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.03.040     Document Type: Article

References (33)

1. [1] World Health Organization, Neonatal and perinatal mortality: country, regional and global estimates. 2006, WHO Libr.
2. [2] Levels and trends in child mortality. Report. 2014, UNICEF, WHO, The World Bank, UN, New York, USA.
3. [3] GBD 2013 Mortality and Causes of Death Collaborators, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:9963 (2015), 117–171.
4. [4] Lawn, J.E., Blencowe, H., Oza, S., You, D., Lee, A.C.C., Waiswa, P., et al. Every newborn: progress, priorities, and potential beyond survival. Lancet, 2014, 189–205.
5. [5] Zaman, K., Roy, E., Arifeen, S.E., Rahman, M., Raqib, R., Wilson, E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359:15 (2008), 1555–1564.
6. [6] Chu, H.Y., Englund, J.A., Maternal immunization. Clin Infect Dis 59:4 (2014), 560–568.
7. [7] Blencowe, H., Lawn, J., Vandelaer, J., Roper, M., Cousens, S., Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol, 39(Suppl. 1), 2010.
8. [8] Swamy, G.K., Phillips Heine, R., Clinical Expert Series. Vaccinations for pregnant women. Obstet Gynecol 125:1 (2015), 212–226.
9. [9] Swamy, G.K., Wheeler, S.M., Neonatal pertussis, cocooning and maternal immunization. Expert Rev Vaccines 13:9 (2014), 1107–1114.
10. [10] Keller-Stanislawski, B., Englund, J.A., Kang, G., Mangtani, P., Neuzil, K., Nohynek, H., et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 32:52 (2014), 7057–7064.
11. [11] Tamma, P.D., Ault, K.A., del Rio, C., Steinhoff, M.C., Halsey, N.A., Omer, S.B., Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 201:6 (2009), 547–552.
12. [12] Munoz, F.M., Weisman, L.E., Read, J.S., Siberry, G., Kotloff, K., Friedman, J., et al. Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy. Clin Infect Dis 59:Suppl. 7 (2014), S415–S427.
13. [13] WHO, Brighton Collaboration, WHO Meeting to develop Brighton Collaboration definitions of key terms used for monitoring the safety of immunization in pregnancy in mothers and newborn children. 2014, 24–25.
14. [14] Kohl, K.S., Gidudu, J., Bonhoeffer, J., Braun, M.M., Buettcher, M., Chen, R.T., et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine 25:31 (2007), 5671–5674.
15. [15] Donegan, K., King, B., Bryan, P., Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ, 349(1), 2014, g4219.
16. [16] Dodds, L., Macdonald, N., Scott, J., Spencer, A., Allen, V.M., McNeil, S., The association between influenza vaccine in pregnancy and adverse neonatal outcomes. J Obstet Gynaecol Can 34:8 (2012), 714–720.
17. [17] Legge, A., Dodds, L., MacDonald, N.E., Scott, J., McNeil, S., Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ 186:4 (2014), E157–E164.
18. [18] Oram, J., Murphy, P., Diagnosis of death. Contin Educ Anaesth Crit Care Pain 11:3 (2011), 77–81.
19. [19] Rubinstein, F., Micone, P., Bonotti, A., Wainer, V., Schwarcz, A., Augustovski, F., et al. Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ, 346(1), 2013, f393.
20. [20] Cleary, B.J., Rice, Ú., Eogan, M., Metwally, N., McAuliffe, F., 2009 A/H1N1 influenza vaccination in pregnancy: uptake and pregnancy outcomes – a historical cohort study. Eur J Obstet Gynecol Reprod Biol 178 (2014), 163–168.
21. [21] Barfield, W.D., Standard terminology for fetal, infant, and perinatal deaths. Pediatrics 128:1 (2011), 177–181.
22. [22] World Health Organization, International Classification of Diseases (ICD). Instruction Manual. 6 Classifications, vol. 2, 2011, 195.
23. [23] Fell, D., Platt, R., Lanes, A., Wilson, K., Kaufman, J., Basso, O., et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG 122:1 (2015), 17–26.
24. [24] Fell, D.B., Sprague, A.E., Liu, N., Yasseen, A.S., Wen, S.-W., Smith, G., et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 102:6 (2012), e33–e40.
25. [25] Ryan, M.A.K., Gumbs, G.R., Conlin, A.M.S., Sevick, C.J., Jacobson, I.G., Snell, K.J., et al. Evaluation of preterm births and birth defects in liveborn infants of US military women who received smallpox vaccine. Birth Defects Res A Clin Mol Teratol 82:7 (2008), 533–539.
26. [26] Harjulehto-mervaala, T., Aro, T., Hiilesmaa, V.K., Hovi, T., Saxen, H., Saxen, L., Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome. Clin Infect Dis, 1986, 414–420.
27. [27] Nordin, J.D., Kharbanda, E.O., Vazquez Benitez, G., Lipkind, H., Vellozzi, C., DeStefano, F., Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 164:5 (2014), 1051–1057.e2.
28. [28] Brighton Collaboration PBWG, Preterm birth: case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. 2016, 1–34.
29. [29] International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline Safety Pharmacology Studies For Human pharmaceuticals S7A Current Step 4 version, dated 8 November 2000, Available from: http://www.ich.org/products/guidelines/safety/article/safety-guidelines.html [cited 30.09.15].
30. [30] CIOMS, Reporting adverse drug reactions: definitions of terms and criteria for their use. South Med J, 102(4), 2000, 345.
31. [31] Schulz, K.F., Altman, D.G., Moher, D., Group, C., CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med, 8(1), 2010, 18.
32. [32] Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D., Stroup, D.F., Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354 (1999), 1896–1900.
33. [33] Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:15 (2000), 2008–2012.